El presente trabajo se ha enfocado en documentar la variabilidad de la práctica
clínica, analizar sus causas y proponer estrategias orientadas a mejorarla; esto
fomenta la toma de decisiones efectivas y seguras, centradas en los pacientes,
por parte de los profesionales de la salud. Entre dichas estrat...
Este documento presenta el resultado del trabajo desarrollado durante la elaboración de la guía de
práctica clínica para el manejo de la enfermedad renal crónica (ERC), estadios 1 al 3a, para la
atención de la población mayor de 18 años en establecimientos de salud del primer nivel de atención
e...
A retinopatía de la prematuridad (ROP) es una enfermedad potencialmente grave que se
presenta en recién nacidos de pretérmino y que afecta a los vasos sanguíneos de la retina en
desarrollo. La ROP es una de las principales patologías causantes de ceguera prevenible en
niños. De manera que todos los...
Wedzicha, JA;
Calverley, PMA;
Albert, RK;
Anzueto, A;
Criner, GJ;
Hurst, JR;
Miravitlles, M;
Papi, A;
Rabe, KF;
Rigau, D;
Sliwinski, P;
Tonia, T;
Vestbo, J;
Wilson, KC;
Krishnan, JA.
This document provides clinical recommendations for the prevention of chronic obstructive pulmonary disease (COPD) exacerbations. It represents a collaborative effort between the European Respiratory Society and the American Thoracic Society.Comprehensive evidence syntheses were performed to summarise al...
Adrenergic beta-2 Receptor Agonists/therapeutic use,
Aminopyridines/therapeutic use,
Benzamides/therapeutic use,
Cyclopropanes/therapeutic use,
Fluoroquinolones/therapeutic use,
Macrolides/therapeutic use,
Muscarinic Antagonists/therapeutic use,
Phosphodiesterase 4 Inhibitors/therapeutic use,
Disease Progression,
Pulmonary Disease, Chronic Obstructive,
Pulmonary Disease, Chronic Obstructive/drug therapy,
Pulmonary Disease, Chronic Obstructive/physiopathology,
Secondary Prevention/standards,
Adrenergic beta-2 Receptor Agonists,
Aminopyridines,
Benzamides,
Cyclopropanes,
Fluoroquinolones,
Macrolides,
Muscarinic Antagonists,
Phosphodiesterase 4 Inhibitors
Miravitlles, M;
Soler-Cataluña, J. J;
Calle, M;
Molina, J;
Almagro, P;
Quintano, J. A;
Trigueros, J. A;
Cosío, B. G;
Casanova, C;
Antonio Riesco, J;
Simonet, P;
Rigau, D;
Soriano, J. B;
Ancochea, J.
La enfermedad pulmonar obstructiva crónica (EPOC) presenta una gran heterogeneidad clínica, por lo que su tratamiento se debe individualizar según el nivel de riesgo y el fenotipo. La Guía española de la EPOC (GesEPOC) estableció por primera vez en 2012 unas pautas de tratamiento farmacológico bas...
Turck, D;
Braegger, CP;
Colombo, C;
Declercq, D;
Morton, A;
Pancheva, R;
Robberecht, E;
Stern, M;
Strandvik, B;
Wolfe, S;
Schneider, SM;
Wilschanski, M.
"BACKGROUND:
Malnutrition is both a frequent feature and a comorbidity of cystic fibrosis (CF), with nutritional status strongly associated with pulmonary function and survival. Nutritional management is therefore standard of care in CF patients. ESPEN, ESPGHAN and ECFS recommended guidelines to cover nu...
Combined Modality Therapy,
Consensus,
Cystic Fibrosis,
Dietary Supplements,
Disease Progression,
Cystic Fibrosis/therapy,
Diet, Healthy,
Malabsorption Syndromes,
Malnutrition,
Nutritional Support,
Malnutrition/prevention & control,
Precision Medicine,
Cystic Fibrosis/diet therapy
Objetivo: Proponer recomendaciones basadas en la evidencia para el diagnóstico y tratamiento de la ERC en pacientes adultos de Colombia....
BACKGROUND: Older people suffering from dementia are at increased risk of malnutrition due to various nutritional problems, and the question arises which interventions are effective in maintaining adequate nutritional intake and nutritional status in the course of the disease. It is of further interest w...
Dementia/diet therapy,
Disease Progression,
Nutritional Support/methods,
Recommended Dietary Allowances,
Fatty Acids, Omega-3/therapeutic use,
Micronutrients/therapeutic use,
Dietary Supplements,
Malnutrition/diet therapy,
Cognition Disorders/diet therapy,
GRADE Approach
"AIM:
Non-radiographic axial spondyloarthritis (nr-axSpA) is axial inflammatory arthritis where plain radiographic damage is not evident. An unknown proportion of these patients will progress to ankylosing spondylitis (AS). The increasing recognition of nr-axSpA has been greatly assisted by the widesprea...
DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the screening, monitoring, and treatment of adults with stage 1 to 3 chronic kidney disease. METHODS: This guideline is based on a systematic evidence review eval...
Renal Insufficiency, Chronic/diagnosis,
Renal Insufficiency, Chronic/drug therapy,
Disease Progression,
Triage,
Angiotensin Receptor Antagonists/therapeutic use,
Angiotensin-Converting Enzyme Inhibitors/therapeutic use,
Antihypertensive Agents/therapeutic use,
Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use,
Hypolipidemic Agents/therapeutic use,
Gemfibrozil/therapeutic use,
Asymptomatic Diseases,
Drug Therapy, Combination,
GRADE Approach
